117 related articles for article (PubMed ID: 30194006)
1. Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort.
Simonds HM; Botha MH; Neugut AI; Van Der Merwe FH; Jacobson JS
Gynecol Oncol; 2018 Nov; 151(2):215-220. PubMed ID: 30194006
[TBL] [Abstract][Full Text] [Related]
2. Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa.
Simonds HM; Wright JD; du Toit N; Neugut AI; Jacobson JS
Cancer; 2012 Jun; 118(11):2971-9. PubMed ID: 22072021
[TBL] [Abstract][Full Text] [Related]
3. HIV Status and Acute Hematologic Toxicity Among Patients With Cervix Cancer Undergoing Radical Chemoradiation.
Simonds HM; Neugut AI; Jacobson JS
Int J Gynecol Cancer; 2015 Jun; 25(5):884-90. PubMed ID: 25853380
[TBL] [Abstract][Full Text] [Related]
4. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
5. Prospective quality of life study of South African women undergoing treatment for advanced-stage cervical cancer.
du Toit GC; Kidd M
Clin Ther; 2015 Oct; 37(10):2324-31. PubMed ID: 26385584
[TBL] [Abstract][Full Text] [Related]
6. Association Between CD4 Count and Chemoradiation Therapy Outcomes Among Cervical Cancer Patients With HIV.
Grover S; Mehta P; Wang Q; Bhatia R; Bvochora-Nsingo M; Davey S; Iyengar M; Shah S; Shin SS; Zetola NM
J Acquir Immune Defic Syndr; 2020 Oct; 85(2):201-208. PubMed ID: 32568769
[TBL] [Abstract][Full Text] [Related]
7. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.
Grover S; Bvochora-Nsingo M; Yeager A; Chiyapo S; Bhatia R; MacDuffie E; Puri P; Balang D; Ratcliffe S; Narasimhamurthy M; Gwangwava E; Tsietso S; Kayembe MKA; Ramogola-Masire D; Dryden-Peterson S; Mahantshetty U; Viswanathan AN; Zetola NM; Lin LL
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):201-210. PubMed ID: 29619965
[TBL] [Abstract][Full Text] [Related]
8. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
[TBL] [Abstract][Full Text] [Related]
9. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
Grover S; Ning MS; Bale M; Lichter KE; Shah S; Bvochora-Nsingo M; Chiyapo S; Balang D; McGinnis GJ; Ralefala T; Moloi T; Luckett R; Ramogola-Masire D; Robertson ES; Zetola NM
Int J Gynecol Cancer; 2021 Sep; 31(9):1220-1227. PubMed ID: 34312220
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology Institute "Prof. Dr. Ion Chiricuta" experience.
Marita A; Ordeanu C; Rancea A; Nicolae T; Nagy VM
J Med Life; 2018; 11(1):42-50. PubMed ID: 29696064
[No Abstract] [Full Text] [Related]
12. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
13. Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.
Trifiletti DM; Swisher-McClure S; Showalter TN; Hegarty SE; Grover S
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1032-44. PubMed ID: 26581141
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
15. The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial.
Minnaar CA; Kotzen JA; Ayeni OA; Naidoo T; Tunmer M; Sharma V; Vangu MD; Baeyens A
PLoS One; 2019; 14(6):e0217894. PubMed ID: 31216321
[TBL] [Abstract][Full Text] [Related]
16. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.
White EC; Khodayari B; Erickson KT; Lien WW; Hwang-Graziano J; Rao AR
Am J Clin Oncol; 2017 Aug; 40(4):386-392. PubMed ID: 25513996
[TBL] [Abstract][Full Text] [Related]
18. HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
Grover S; MacDuffie EC; Wang Q; Bvochora-Nsingo M; Bhatia RK; Balang D; Chiyapo SP; Luckett R; Ramogola-Masire D; Dryden-Peterson SL; Lin LL; Shin SS; Zetola NM
Cancer; 2019 May; 125(10):1645-1653. PubMed ID: 30801696
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus infection and invasive cervical cancer in South Africa.
Lomalisa P; Smith T; Guidozzi F
Gynecol Oncol; 2000 Jun; 77(3):460-3. PubMed ID: 10831360
[TBL] [Abstract][Full Text] [Related]
20. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
